VE

Venkateswarlu Elluru

Active Director Designated Partner DIN 10603314
DIN 10603314 First appointment Feb 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkateswarlu Elluru

Data last updated:

Venkateswarlu Elluru is a Designated Partner at Stenovel Biologics Llp (since 2024). The company operates in Healthcare.

DIN 10603314
Primary Designation Designated Partner
Industry Healthcare
First Appointment 06 Feb 2024
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Feb 20242019Active

Board colleagues of Venkateswarlu Elluru

NameDINCompanyDesignation
Bharata Reddy Ganta08586902Stenovel Biologics LlpDesignated Partner
Mohini Gunta09378719Stenovel Biologics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Stenovel Biologics Llp
Premium access

Shareholding and investment profile for Venkateswarlu Elluru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkateswarlu Elluru

Venkateswarlu Elluru currently holds 1 directorship: Stenovel Biologics Llp (Designated Partner, since 06 Feb 2024).

Venkateswarlu Elluru was first appointed on 06 Feb 2024 as Designated Partner at Stenovel Biologics Llp.

The current boards of Venkateswarlu Elluru's companies include Bharata Reddy Ganta (Stenovel Biologics Llp), Mohini Gunta (Stenovel Biologics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available